<DOC>
	<DOC>NCT01561443</DOC>
	<brief_summary>This is the first study focused on features/stereotypes of the first and second-line treatment patterns in Russia, comparison of different treatments, and determination of effective hormone treatment patterns in real-life practice with evaluation of pharmacoeconomic aspects. Study LINE is designed for collection of data on clinical effectiveness of second-line hormone treatment and quality of life in patients with breast cancer(BC).</brief_summary>
	<brief_title>LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer</brief_title>
	<detailed_description>LINE: Treatment patterns in postmenopausaL women wIth hormone receptor positive breast caNcEr</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Postmenopausal women with hormone receptorpositive breast cancer: Recurrence after the adjuvant hormone therapy; Or initially inoperable locally advanced or metastatic breast cancer progressed after the first line hormone therapy; Ability to read and write and complete questionnaires Provision of written informed consent Patients who have already been prescribed therapy with the abovementioned lines and who can continue on the prescribed therapy in the investigator's opinion according to his/her regular clinical practice and cure As per study design, to ensure high validity of data and to obtain accurate information on reallife practice, Patients currently participating in other clinical studies will not be included in this study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Breast cancer,</keyword>
	<keyword>hormone positive,</keyword>
</DOC>